Brainsway (BRSYF) EBIT Margin (2018 - 2026)
Brainsway's (BRSYF) quarterly EBIT Margin came in at 13.98% in Q2 2026, up 940.0% on a YoY basis from 1.34% in Q2 2025, and up 8.27% quarter-over-quarter from 12.91% in Q1 2026.
Powered by 
Analysis
Brainsway (BRSYF) EBIT Margin (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported EBIT Margin for 9 consecutive years, with 13.98% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin rose 940.0% year-over-year to 13.98%; the trailing twelve-month figure through Jun 2026 stood at 12.46% (up 841.0% YoY), and the FY2025 full-year result was 8.28%, up 489.0% from the prior year.
- EBIT Margin grew to 13.98% in Q2 2026 per BRSYF's latest filing, from 12.91% in the prior quarter.
- Across five years, EBIT Margin topped out at 13.98% in Q2 2026 and bottomed at 94.23% in Q3 2022.
- Historically, EBIT Margin has averaged 11.63% across 5 years, with a median of 2.36% in 2023.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin plunged 7894 bps in 2022, then jumped 9263 bps in 2023.
- Over 5 years, EBIT Margin stood at 71.66% in 2022, then surged by 103 bps to 2.04% in 2023, then surged by 85 bps to 3.78% in 2024, then soared by 249 bps to 13.17% in 2025, then grew by 6 bps to 13.98% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 13.98%, 12.91%, and 13.17% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 13.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.98% |
| Mar 31, 2026 | 12.91% |
| Dec 31, 2025 | 13.17% |
| Sep 30, 2025 | 9.27% |
| Jun 30, 2025 | 4.58% |
| Mar 31, 2025 | 4.99% |
| Dec 31, 2024 | 3.78% |
| Sep 30, 2024 | 2.68% |
| Jun 30, 2024 | 5.86% |
| Mar 31, 2024 | 1.02% |
| Dec 31, 2023 | 2.04% |
| Sep 30, 2023 | -1.60% |
| Jun 30, 2023 | -17.15% |
| Mar 31, 2023 | -55.35% |
| Dec 31, 2022 | -71.66% |
| Sep 30, 2022 | -94.23% |
| Jun 30, 2022 | -25.08% |
| Mar 31, 2022 | -18.59% |
| Dec 31, 2021 | -17.14% |
| Sep 30, 2021 | -15.30% |